Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
暂无分享,去创建一个
Manel Esteller | M. Esteller | J. Sanchez-Mut | R. G. Urdinguio | Rocio G Urdinguio | Jose V Sanchez-Mut
[1] S. Haggarty,et al. HDAC2 negatively regulates memory formation and synaptic plasticity , 2009, Nature.
[2] Kristian Helin,et al. The emerging functions of histone demethylases. , 2008, Current opinion in genetics & development.
[3] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[4] M. Druse,et al. S100B-mediated protection against the pro-apoptotic effects of ethanol on fetal rhombencephalic neurons , 2007, Brain Research.
[5] R. Ophoff,et al. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration , 2008, Human molecular genetics.
[6] D. Higgs,et al. Loss of Atrx Affects Trophoblast Development and the Pattern of X-Inactivation in Extraembryonic Tissues , 2006, PLoS genetics.
[7] M. Guenther,et al. Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.
[8] A. Hanauer,et al. Coffin-Lowry syndrome: clinical and molecular features , 2002, Journal of medical genetics.
[9] C. Polman,et al. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis , 2009, The Lancet Neurology.
[10] Robert H. Brown,et al. Amyotrophic Lateral Sclerosis-Associated SOD1 Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria , 2004, Neuron.
[11] K. Kyvik,et al. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study , 2005, Multiple sclerosis.
[12] Ruben Abagyan,et al. Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.
[13] I. Verma,et al. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. , 2008, The American journal of pathology.
[14] Xiuli Wang,et al. Gcn5- and Elp3-induced histone H3 acetylation regulates hsp70 gene transcription in yeast. , 2008, The Biochemical journal.
[15] P. Wade,et al. MBD family proteins: reading the epigenetic code , 2006, Journal of Cell Science.
[16] S. Horvath,et al. Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.
[17] R. Dingledine,et al. Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus , 2002, The Journal of Neuroscience.
[18] T. Kouzarides. Chromatin Modifications and Their Function , 2007, Cell.
[19] N. Belyaev,et al. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease , 2009, EMBO reports.
[20] T. Nagatsu,et al. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.
[21] T. Bruxner,et al. A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development , 2008, Genome Biology.
[22] I. Krantz,et al. Mutations in the chromatin‐associated protein ATRX , 2008, Human mutation.
[23] E. Schorry,et al. Genotype–phenotype correlations in Rubinstein–Taybi syndrome , 2008, American journal of medical genetics. Part A.
[24] R. Wells,et al. Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia , 2008, Nucleic acids research.
[25] M. Fraga,et al. Histone H3 and H4 Modification Profiles in a Rett Syndrome Mouse Model , 2007, Epigenetics.
[26] J. Sng,et al. Histone modifications in kainate‐induced status epilepticus , 2006, The European journal of neuroscience.
[27] Monika S. Kowalczyk,et al. Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX , 2007, Proceedings of the National Academy of Sciences.
[28] S. Sakoda,et al. Benefit of valproic acid in suppressing disease progression of ALS model mice , 2004, The European journal of neuroscience.
[29] K. Kyvik,et al. Risk for multiple sclerosis in dizygotic and monozygotic twins , 2005, Multiple sclerosis.
[30] D. Chuang,et al. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model , 2008, Neuroscience.
[31] M. Esteller,et al. Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome , 2008, PloS one.
[32] A. Pombo,et al. Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Jeanmougin,et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. , 1996, The EMBO journal.
[34] M. Fraga,et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.
[35] W. Reik,et al. Epigenetic Reprogramming in Mammalian Development , 2001, Science.
[36] M. Esteller. Epigenetics in evolution and disease , 2008, The Lancet.
[37] R. Hennekam. Rubinstein–Taybi syndrome , 2005, European Journal of Human Genetics.
[38] F. Mastronardi,et al. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: A contribution to the current debate on disease pathogenesis , 2008, Progress in Neurobiology.
[39] A. Minagar,et al. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. , 2007, International review of neurobiology.
[40] A. Wilkie,et al. X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: localization to Xq12-q21.31 by X inactivation and linkage analysis. , 1992, American journal of human genetics.
[41] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[42] Yong-Yeon Cho,et al. The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction. , 2005, Cancer research.
[43] H. Schaeffer,et al. Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.
[44] P. Mcgeer,et al. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide , 2001, Neuroscience Letters.
[45] G. Mandel,et al. Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology , 2009, Nature Neuroscience.
[46] N. Risch,et al. Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Sassone-Corsi,et al. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Fraga,et al. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients , 2004, Human Genetics.
[49] D. Higgs,et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation , 2000, Nature Genetics.
[50] C. Glass,et al. Induced ncRNAs Allosterically Modify RNA Binding Proteins in cis to Inhibit Transcription , 2008, Nature.
[51] Sun-Chong Wang,et al. Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.
[52] Huda Y. Zoghbi,et al. The Story of Rett Syndrome: From Clinic to Neurobiology , 2007, Neuron.
[53] N. Landsberger,et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. , 2005, Human molecular genetics.
[54] A. Nordberg,et al. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels , 2008, Neurobiology of Aging.
[55] G. Brady,et al. The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: A possible role in multiple sclerosis , 1986, Journal of neuroscience research.
[56] M. Esteller. Relevance of DNA methylation in the management of cancer. , 2003, The Lancet. Oncology.
[57] N. Youngson,et al. Transgenerational epigenetic effects. , 2008, Annual review of genomics and human genetics.
[58] M. Stratton,et al. Mutations in the RSK2(RPS6KA3) gene cause Coffin–Lowry syndrome and nonsyndromic X‐linked mental retardation , 2006, Clinical genetics.
[59] M. Esteller. Rett Syndrome: The First Forty Years 1966-2006 , 2007, Epigenetics.
[60] B. Weinshenker,et al. Men transmit MS more often to their children vs women , 2006, Neurology.
[61] C. Allis,et al. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. , 2008, Mutation research.
[62] T. Spector,et al. Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Gunzburg,et al. Structural Basis for the Recognition and Cross-linking of Amyloid Fibrils by Human Apolipoprotein E* , 2007, Journal of Biological Chemistry.
[64] Kunlin Chen,et al. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. , 2009, Biochemical and biophysical research communications.
[65] Shiu-Hwa Yeh,et al. Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. , 2004, Molecular pharmacology.
[66] S. Hersch,et al. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. , 2007, Human molecular genetics.
[67] Y. Suh,et al. Inhibition of histone deacetylation enhances the neurotoxicity induced by the c‐terminal fragments of amyloid precursor protein , 2004, Journal of neuroscience research.
[68] I. Takasaki,et al. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions , 2009, Neuroscience Research.
[69] T. Saido,et al. Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.
[70] Fabrice P Cordelières,et al. Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation , 2007, The Journal of Neuroscience.
[71] D. Schoenfeld,et al. Phase 2 study of sodium phenylbutyrate in ALS , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[72] G. Harauz,et al. Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[73] D. Higgs,et al. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome) , 1995, Cell.
[74] Y. Jong,et al. Treatment of spinal muscular atrophy by sodium butyrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[75] Andrew J. Bannister,et al. The CBP co-activator is a histone acetyltransferase , 1996, Nature.
[76] Y. Itoyama,et al. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. , 2006, Biochemical and biophysical research communications.
[77] A. Bird,et al. Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.
[78] A. Feinberg. Phenotypic plasticity and the epigenetics of human disease , 2007, Nature.
[79] R. Holliday. DNA methylation and epigenetic defects in carcinogenesis. , 1987, Mutation research.
[80] B. Oostra,et al. In vitro reactivation of the FMR1 gene involved in fragile X syndrome. , 1998, Human molecular genetics.
[81] Raoul C. M. Hennekam,et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.
[82] Y. She,et al. Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry. , 2005, Biochemistry.
[83] M. Mayford,et al. CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation , 2004, Neuron.
[84] R. Jaenisch,et al. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[85] Jonathan Pevsner,et al. DNA methylation signatures within the human brain. , 2007, American journal of human genetics.
[86] T. Bestor,et al. The DNA methyltransferases of mammals. , 2000, Human molecular genetics.
[87] D. Housman,et al. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[88] R. Jaenisch,et al. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.
[89] Samuel F. Berkovic,et al. Mechanisms of human inherited epilepsies , 2009, Progress in Neurobiology.
[90] J. Gécz,et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. , 2004, American journal of human genetics.
[91] G. Carraz,et al. [Pharmacodynamic properties of N-dipropylacetic acid]. , 1963, Therapie.
[92] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[93] R. Gibbons. Alpha thalassaemia-mental retardation, X linked , 2006, Orphanet journal of rare diseases.
[94] M. Mehler. Epigenetic principles and mechanisms underlying nervous system functions in health and disease , 2008, Progress in Neurobiology.
[95] H. Zoghbi,et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. , 2004, Human molecular genetics.
[96] T. Russo,et al. Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks , 2009, Proceedings of the National Academy of Sciences.
[97] R. Bourtchouladze,et al. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction , 2006, Cellular and Molecular Life Sciences.
[98] J A Eisen,et al. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. , 1995, Nucleic acids research.
[99] Christopher K. Glass,et al. Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.
[100] J. Qin,et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[101] Ankita Patel,et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males , 2006, Genetics in Medicine.
[102] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[103] Pascal G. P. Martin,et al. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator , 2005, The Journal of cell biology.
[104] F. Gao. Posttranscriptional control of neuronal development by microRNA networks , 2008, Trends in Neurosciences.
[105] R. Ferrante,et al. Modulation of nucleosome dynamics in Huntington's disease. , 2007, Human molecular genetics.
[106] T. Deguchi,et al. Phosphorylation by extracellular signal‐regulated kinase of a multidomain adaptor protein, vinexin, at synapses , 2007, Journal of neurochemistry.
[107] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[108] R. Jaenisch,et al. DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.
[109] Miguel Alaminos,et al. A microarray-based DNA methylation study of glioblastoma multiforme , 2009, Epigenetics.
[110] E. Kalkhoven,et al. CBP and p300: HATs for different occasions. , 2004, Biochemical pharmacology.
[111] E. Lander,et al. The Mammalian Epigenome , 2007, Cell.
[112] S. Timsit,et al. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. , 1998, Human molecular genetics.
[113] E. Zackai,et al. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome , 1996, Nature.
[114] Hyoung-Gon Lee,et al. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes , 2008, AGE.
[115] Marcelo A Wood,et al. Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. , 2005, Learning & memory.
[116] J H RUBINSTEIN,et al. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. , 1963, American journal of diseases of children.
[117] D. Harvey,et al. Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions , 2009, The Journal of Neuroscience.
[118] P. Riederer,et al. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability , 2008, Neurobiology of Disease.
[119] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[120] J. Clayton-Smith,et al. Clinical and hematologic aspects of the X-linked α-thalassemia/mental retardation syndrome (ATR-X) , 1995 .
[121] R. Ferrante,et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease , 2006, Proceedings of the National Academy of Sciences.
[122] J. Parvin,et al. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. , 2006, Human molecular genetics.
[123] C. Poser. The multiple sclerosis trait and the development of multiple sclerosis: Genetic vulnerability and environmental effect , 2006, Clinical Neurology and Neurosurgery.
[124] Scar,et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.
[125] Joel M Stein,et al. Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.
[126] Jan Hillert,et al. HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis , 2007, PloS one.
[127] N. Bérubé,et al. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. , 2000, Human molecular genetics.
[128] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[129] I. Young,et al. The Coffin-Lowry syndrome. , 1988, Journal of medical genetics.
[130] M. Bieda,et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes , 2007, Proceedings of the National Academy of Sciences.
[131] K. Wigglesworth,et al. ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. , 2004, Developmental biology.
[132] A. Bird. DNA methylation patterns and epigenetic memory. , 2002, Genes & development.
[133] S. Perlman,et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia , 2006, Nature chemical biology.
[134] G. Stephanopoulos,et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.
[135] A. Sadovnick,et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. , 2008, Human molecular genetics.
[136] E. Nestler,et al. Histone Modifications at Gene Promoter Regions in Rat Hippocampus after Acute and Chronic Electroconvulsive Seizures , 2004, The Journal of Neuroscience.
[137] S. Koschmieder,et al. S100A2 Induces Metastasis in Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.
[138] M. Esteller. Epigenetics in cancer. , 2008, The New England journal of medicine.
[139] Andrew L Kung,et al. Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation. , 2008, Human molecular genetics.
[140] A. Harel-Bellan,et al. Mitogen-Regulated RSK2-CBP Interaction Controls Their Kinase and Acetylase Activities , 2001, Molecular and Cellular Biology.
[141] T. Saido,et al. Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?' , 2000, Nature Medicine.
[142] D. Housman,et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.
[143] M. Cobb,et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.
[144] M. Esteller,et al. Proteins that bind methylated DNA and human cancer: reading the wrong words , 2008, British Journal of Cancer.
[145] C. Ackerley,et al. Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.
[146] D. Krainc,et al. Sodium phenylbutyrate in Huntington's disease: A dose‐finding study , 2007, Movement disorders : official journal of the Movement Disorder Society.
[147] Masatoshi Hagiwara,et al. Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.
[148] J. De Belleroche,et al. Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. , 2005, Brain research. Molecular brain research.
[149] W. Gerald,et al. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. , 2004, Journal of the National Cancer Institute.
[150] A. Feinberg,et al. Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.
[151] A. Noor,et al. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated , 2007, Journal of neuroscience research.
[152] M. Esteller. Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.
[153] M. Paz,et al. CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas , 2004, Clinical Cancer Research.
[154] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[155] R. Hennekam,et al. Growth in the Rubinstein-Taybi syndrome. , 2005, American journal of medical genetics. Supplement.
[156] F. Mastronardi,et al. The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis , 2006, Neurochemical Research.
[157] John Peterson Myers,et al. Environmental Exposures and Gene Regulation in Disease Etiology , 2007, Environmental health perspectives.
[158] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[159] D. Geschwind,et al. HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model , 2008, PloS one.
[160] J. Gécz,et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.
[161] J. Haines,et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. , 1998, Human molecular genetics.
[162] J. Strouboulis,et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.
[163] A. Bird,et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation , 2007, Proceedings of the National Academy of Sciences.
[164] E. Seemanová,et al. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS , 2005, Human Genetics.
[165] H. Harbo,et al. Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis , 2007, Nature Genetics.
[166] Li-Huei Tsai,et al. Recovery of learning and memory is associated with chromatin remodelling , 2007, Nature.
[167] R. Touraine,et al. A syndromic form of X-linked mental retardation: the Coffin-Lowry syndrome , 2002, European Journal of Pediatrics.
[168] F. Dick,et al. Loss of ATRX leads to chromosome cohesion and congression defects , 2008, The Journal of cell biology.
[169] A. Cantani,et al. Rubinstein-Taybi syndrome. Review of 732 cases and analysis of the typical traits. , 1998, European review for medical and pharmacological sciences.
[170] Stephen L. Hauser,et al. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis , 2008, Nature Reviews Genetics.
[171] M. Beal,et al. Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease* , 2005, Journal of Biological Chemistry.
[172] E. Bézard,et al. Striatal histone modifications in models of levodopa‐induced dyskinesia , 2008, Journal of neurochemistry.
[173] D. Trabzuni,et al. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. , 2007, Human molecular genetics.
[174] Stephen T. C. Wong,et al. MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.
[175] B. Wirth,et al. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition , 2008, Human molecular genetics.
[176] Nathan R. Wilson,et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice , 2009, Proceedings of the National Academy of Sciences.
[177] D. Molfese,et al. Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.
[178] M. Z. Cader,et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. , 2005, Human molecular genetics.
[179] Johan T den Dunnen,et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.
[180] R. D. L. Fuente,et al. ATRX marks the inactive X chromosome (Xi) in somatic cells and during imprinted X chromosome inactivation in trophoblast stem cells , 2009, Chromosoma.
[181] E. Kandel,et al. Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice A Model for the Cognitive Deficit in Rubinstein-Taybi Syndrome and Its Amelioration , 2004, Neuron.
[182] M. J. Barratt,et al. Phosphoacetylation of histone H3 on c‐fos‐ and c‐jun‐associated nucleosomes upon gene activation , 2000, The EMBO journal.
[183] A. Ferguson-Smith,et al. Mechanisms regulating imprinted genes in clusters. , 2007, Current opinion in cell biology.
[184] Manel Esteller,et al. Towards the Human Cancer Epigenome: A First Draft of Histone Modifications , 2005, Cell cycle.